This PDF file includes:
Fig. S1. Fine-mapped PCa risk SNPs in 12q13 region. Fig. S2 . SNP rs55958994 is associated with enhancer activity in cervical, liver, and breast cancer cell lines. Fig. S3 . CRISPR-Cas9-mediated deletion of the rs55958994-associated enhancer. Fig. S4 . Re-expression of target genes in enhancer-deleted PCa cells promotes cancer initiation, growth, and progression. Fig. S5 . Re-expression of KRT8 in enhancer-deleted PCa cells did not rescue the defect of soft agar colony formation and invasive migration ability and the decrease in CSC population. Fig. S6 . Validation of target gene expression in enhancer KO cells. Fig. S7 . 3C-PCR analysis confirms interaction of the rs55958994-associated enhancer and target gene loci. Fig. S8 . Comparison of transcriptomic changes following deletion of the rs55958994-associated enhancer and mutation of rs55958994. Table S1 . Guide RNAs for CRISPR-Cas9-mediated deletions. Table S2 . Primers used in qRT-PCR experiment. Table S3 . Primers for 3C-PCR assay. Table S4 . Guide RNAs for CRISPR-Cas9-mediated SNP editing. 
